...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Quantitative Measurement of Lipoprotein Particles Containing Both Apolipoprotein AIV and Apolipoprotein B in Human Plasma by a Noncompetitive ELISA
【24h】

Quantitative Measurement of Lipoprotein Particles Containing Both Apolipoprotein AIV and Apolipoprotein B in Human Plasma by a Noncompetitive ELISA

机译:通过非竞争性ELISA定量测定血浆中同时含有载脂蛋白AIV和载脂蛋白B的脂蛋白颗粒

获取原文

摘要

Background: A reliable method for plasma would be useful to investigate the role of apolipoprotein (apo) AIV when associated with apo B-containing or triglyceride-rich lipoproteins.Method: We used a sandwich ELISA to quantify lipoprotein B:AIV particles (Lp B:AIVf; lipoproteins containing at least apo B and apo AIV) in plasma. The method used microtiter plates coated with purified anti-apo B immunoglobulins that selectively retained apo B-containing particles. Lipoproteins containing both apo B and apo AIV were distinguished from those containing only apo B by use of a peroxidase-labeled anti-apo AIV antibody. These subspecies were revealed by ABTS? reagent and further quantified by spectrophotometry. Results were expressed in mg/L apo AIV associated with apo B. This method was applied to samples with different cholesterol and triglyceride concentrations.Results: The developed sandwich ELISA method identified and quantified Lp B:AIVf in plasma samples. Within- and between-run CVs were ~10%, and analytical recoveries were 95–107%. Results were not significantly influenced by addition of triglycerides or by storage at ?20 °C (up to 9 months). Under these conditions, plasma Lp B:AIVf concentrations were statistically higher in hypercholesterolemic and mixed hyperlipidemic individuals (53 ± 13 mg/L; P 0.001 and 70 ± 18 mg/L; P 0.001, respectively) than in normolipidemic individuals (43 ± 12 mg/L). Lp B:AIVf concentration appeared to be well correlated with total cholesterol, triglycerides, LDL-cholesterol, and apo B. These results were in contrast to total apo AIV, which was not different between dyslipidemic and normolipidemic individuals.Conclusions: The developed ELISA method for Lp B:AIVf in plasma combines specificity, reliability, and speed. The increase in Lp B:AIVf concentrations in various dyslipidemic states, together with a lack of change in total apo AIV concentrations, suggests a redistribution of apo AIV toward apo B-containing lipoproteins when these lipoproteins accumulate.
机译:背景:一种可靠的血浆分析方法将有助于研究载脂蛋白(apo)AIV与含载脂蛋白B或富含甘油三酸酯的脂蛋白结合时的作用。方法:我们使用夹心ELISA定量了脂蛋白B:AIV颗粒(Lp B :AIVf;血浆中至少包含apo B和apo AIV的脂蛋白。该方法使用涂有纯化的抗apo B免疫球蛋白的微量滴定板,选择性地保留了含apo B的颗粒。通过使用过氧化物酶标记的抗apo AIV抗体,将同时包含apo B和apo AIV的脂蛋白与仅包含apo B的脂蛋白区分开。这些亚种是由ABTS揭示的吗?试剂并通过分光光度法进一步定量。结果以mg / L与载脂蛋白B相关的载脂蛋白AIV表示。该方法适用于不同胆固醇和甘油三酸酯浓度的样品。结果:开发的夹心ELISA方法鉴定并定量了血浆样品中的脂蛋白B:AIVf。批内和批间CV约为10%,分析回收率为95-107%。加入甘油三酸酯或在?20°C下保存(最多9个月)对结果没有显着影响。在这些条件下,高胆固醇血症和混合性高脂血症患者的血浆Lp B:AIVf浓度在统计学上高于正常血脂患者(43±13 mg / L; P <0.001和70±18 mg / L; P <0.001)。 ±12 mg / L)。 Lp B:AIVf的浓度似乎与总胆固醇,甘油三酸酯,LDL-胆固醇和载脂蛋白B密切相关。这些结果与总载脂蛋白AIV相反,这在血脂异常和正常血脂异常的个体之间没有差异。结论:发达的ELISA方法用于血浆中Lp B:AIVf的试剂结合了特异性,可靠性和速度。各种血脂异常状态下Lp B:AIVf浓度的增加,以及总载脂蛋白AIV浓度变化的缺乏,表明当这些脂蛋白积聚时,载脂蛋白AIV向含载脂蛋白B的脂蛋白重新分布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号